Abstract | BACKGROUND: OBJECTIVE: SETTING: METHODS: A Bu/Cy preparative regimen was used, modified by Flu 90 mg/m(2) and Ara-c 6 g/m(2) in 57 unselected patients (median age 37 years) with hematological myeloid malignancies. The patients were to receive allogeneic hematopoietic stem cell transplantation (allo-HSCT). Thirteen patients had high-risk leukemia, fifty patients had HLA matched sibling donors while seven patients had HLA mismatched sibling donors. Cy was given 50 mg/kg/day for 2 days while Bu was given 3.2 mg/kg/day intravenously for 3 days. MAIN OUTCOME MEASURE: RESULTS: Extramedullar toxicity was relatively limited; the incidence of treatment-related mortality (TRM) within 100 days was 3.5 %. The incidence of grade II-IV, grade III-IV acute graft versus host disease (GVHD) and chronic GVHD of the evaluable patients were 21.1, 8.8 and 36.4 %, respectively. With a median follow up of 59 (13-96.5) months, TRM and relapse rate (RR) at eight years were 24.1 ± 5.8 and 14.7 ± 4.8 %, respectively. Disease free survival at eight years was 67.9 ± 6.2 % for the entire group, 60.0 ± 8.9 % for patients with AML, 77.3 ± 8.9 % for patients with CML, 70.0 ± 6.5 and 42.9 ± 18.7 % or matched sibling and mismatched sibling HSCT respectively. CONCLUSION:
|
Authors | Xiaojin Cai, Jialing Wei, Yi He, Dongling Yang, Erlie Jiang, Yong Huang, Mingzhe Han, Sizhou Feng |
Journal | International journal of clinical pharmacy
(Int J Clin Pharm)
Vol. 37
Issue 1
Pg. 44-52
(Feb 2015)
ISSN: 2210-7711 [Electronic] Netherlands |
PMID | 25432692
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Immunosuppressive Agents
- Cyclophosphamide
- Busulfan
|
Topics |
- Adolescent
- Adult
- Busulfan
(administration & dosage)
- Child
- Cyclophosphamide
(administration & dosage)
- Disease-Free Survival
- Female
- Hematopoietic Stem Cell Transplantation
(methods)
- Humans
- Immunosuppressive Agents
(administration & dosage)
- Leukemia, Myeloid, Acute
(diagnosis, therapy)
- Male
- Middle Aged
- Transplantation Conditioning
(methods)
- Transplantation, Homologous
- Young Adult
|